2-Chloro-N-cyclopentylnicotinamide

Catalog No.: 
ACVVBW464
CAS No.: 
57841-73-3
Molecular Formula: 
C11H13ClN2O
Molecular Weight: 
224.69
2-Chloro-N-cyclopentylnicotinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$430.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-N-cyclopentylnicotinamide
IUPAC Name2-chloro-N-cyclopentylnicotinamide
MDL No.MFCD00848989
Molecular FormulaC11H13ClN2O
Molecular Weight224.69
SMILESO=C(NC1CCCC1)C2=C(Cl)N=CC=C2
InChI KeyROXFDGGIMQZRPV-UHFFFAOYSA-N
Synonym2-chloro-N-cyclopentylnicotinamide;3-Pyridinecarboxamide, 2-chloro-N-cyclopentyl-;2-Chloro-N-cyclopentyl-3-pyridinecarboxamide
CAS No.57841-73-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVVBW464 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCOGW615 route compound structure diagram
    ACCOGW61549609-84-9In Stock
  4. Then
  5. ACVVBW464 route product structure diagram
    ACVVBW46457841-73-3
Inquiry

2. ACVVBW464 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIFBX327 route compound structure diagram
    ACIFBX32740134-18-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVVBW464 route product structure diagram
    ACVVBW46457841-73-3
Inquiry

3. ACVVBW464 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVVBW464 route product structure diagram
    ACVVBW46457841-73-3
Inquiry

Comments (0)